Literature DB >> 12458389

Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.

William D Leslie1, Jacqueline O Dupont, Bohdan Bybel, Karl T Riese.   

Abstract

Technetium-99m sestamibi imaging for parathyroid adenoma localization has been performed using both dual-tracer subtraction and double-phase single-tracer washout techniques. The relative accuracy of these two techniques is uncertain. We have developed a modified imaging technique which combines both approaches and have directly compared them in a series of patients with surgically explored hyperparathyroidism. Initial injection of (99m)Tc-pertechnetate 50 MBq was followed by continuous dynamic imaging of the anterior neck for 30 min. (99m)Tc-sestamibi 1,000 MBq was injected intravenously at the midpoint of the acquisition. Delayed images were performed after 2 h. We blindly reviewed 88 consecutive cases of surgically explored hyperparathyroidism that had undergone preoperative scintigraphic localization with this procedure. Images were reformatted to display subtraction-only, early/delayed sestamibi-only and combined images. Scans were reviewed in random order. Of the 68 cases with solitary parathyroid adenoma, the sestamibi-only images gave correct localization in 49 (72%) while there was a statistically significant improvement in accuracy using the subtraction-only images (58 of 68, 85%, P=0.05) and the combined images (61 of 68, 90%, P=0.0015). Reader confidence was also greater with the subtraction-only and combined images than with the sestamibi-only images. Scan performance with parathyroid hyperplasia was less satisfactory. Although the largest gland was usually correctly identified, hyperplasia was difficult to distinguish from a solitary adenoma. Dual-tracer subtraction parathyroid imaging is superior to double-phase sestamibi-only imaging. The washout data may provide additional information in some cases, however, and an approach that combines both techniques may be optimal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458389     DOI: 10.1007/s00259-002-0944-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  6 in total

1.  Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients.

Authors:  Radu Mihai; Fergus Gleeson; Ian D Buley; Derek E Roskell; Gregory P Sadler
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

2.  Value of 123I-subtraction and single-photon emission computed tomography in addition to planar 99mTc-MIBI scintigraphy before parathyroid surgery.

Authors:  Francisca H Jorna; Pieter L Jager; Tjin H Que; Clara Lemstra; John T M Plukker
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

3.  Sensitivity and Specificity of Dual-Isotope 99mTc-Tetrofosmin and 123I Sodium Iodide Single Photon Emission Computed Tomography (SPECT) in Hyperparathyroidism.

Authors:  Michael Sommerauer; Carmen Graf; Niklaus Schäfer; Gerhard Huber; Paul Schneider; Rudolf Wüthrich; Christoph Schmid; Hans Steinert
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

4.  Oesophageal conduit - a cause of diffuse mediastinal uptake on thyroid scintigraphy.

Authors:  Luke I Sonoda; Kottekkattu K Balan
Journal:  Mol Imaging Radionucl Ther       Date:  2013-12-10

5.  (99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism.

Authors:  Eeva M Ryhänen; Jukka Schildt; Ilkka Heiskanen; Mika Väisänen; Aapo Ahonen; Eliisa Löyttyniemi; Camilla Schalin-Jäntti; Matti J Välimäki
Journal:  Int J Mol Imaging       Date:  2015-02-01

6.  Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patients.

Authors:  David Morland; Paul Lalire; Sophie Deguelte; Mohamad Zalzali; Capucine Richard; Sébastien Dejust; Camille Boulagnon; Sang Ly; Dimitri Papathanassiou; Brigitte Delemer
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.